AntiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation

Research output: Contribution to journalArticleResearchpeer review

Authors

  • Kai Blin
  • Simon Shaw
  • Hannah E. Augustijn
  • Zachary L. Reitz
  • Friederike Biermann
  • Mohammad Alanjary
  • Artem Fetter
  • Barbara R. Terlouw
  • William W. Metcalf
  • Eric J.N. Helfrich
  • Gilles P. Van Wezel
  • Marnix H. Medema
  • Tilmann Weber

Research Organisations

External Research Organisations

  • Novo Nordisk Foundation Center for Biosustainability
  • Leiden University
  • Wageningen University and Research
  • Goethe University Frankfurt
  • LOEWE Center for Translational Biodiversity Genomics
  • University of Illinois at Urbana-Champaign
View graph of relations

Details

Original languageEnglish
Pages (from-to)W46-W50
JournalNucleic acids research
Volume51
Issue numberW1
Early online date4 May 2023
Publication statusPublished - 5 Jul 2023

Abstract

Microorganisms produce small bioactive compounds as part of their secondary or specialised metabolism. Often, such metabolites have antimicrobial, anticancer, antifungal, antiviral or other bio-Activities and thus play an important role for applications in medicine and agriculture. In the past decade, genome mining has become a widely-used method to explore, access, and analyse the available biodiversity of these compounds. Since 2011, the 'antibiotics and secondary metabolite analysis shell-antiSMASH' (https://antismash.secondarymetabolites.org/) has supported researchers in their microbial genome mining tasks, both as a free to use web server and as a standalone tool under an OSI-Approved open source licence. It is currently the most widely used tool for detecting and characterising biosynthetic gene clusters (BGCs) in archaea, bacteria, and fungi. Here, we present the updated version 7 of antiSMASH. antiSMASH 7 increases the number of supported cluster types from 71 to 81, as well as containing improvements in the areas of chemical structure prediction, enzymatic assembly-line visualisation and gene cluster regulation.

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Genetics

Cite this

AntiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation. / Blin, Kai; Shaw, Simon; Augustijn, Hannah E. et al.
In: Nucleic acids research, Vol. 51, No. W1, 05.07.2023, p. W46-W50.

Research output: Contribution to journalArticleResearchpeer review

Blin, K, Shaw, S, Augustijn, HE, Reitz, ZL, Biermann, F, Alanjary, M, Fetter, A, Terlouw, BR, Metcalf, WW, Helfrich, EJN, Van Wezel, GP, Medema, MH & Weber, T 2023, 'AntiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation', Nucleic acids research, vol. 51, no. W1, pp. W46-W50. https://doi.org/10.1093/nar/gkad344
Blin, K., Shaw, S., Augustijn, H. E., Reitz, Z. L., Biermann, F., Alanjary, M., Fetter, A., Terlouw, B. R., Metcalf, W. W., Helfrich, E. J. N., Van Wezel, G. P., Medema, M. H., & Weber, T. (2023). AntiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation. Nucleic acids research, 51(W1), W46-W50. https://doi.org/10.1093/nar/gkad344
Blin K, Shaw S, Augustijn HE, Reitz ZL, Biermann F, Alanjary M et al. AntiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation. Nucleic acids research. 2023 Jul 5;51(W1):W46-W50. Epub 2023 May 4. doi: 10.1093/nar/gkad344
Blin, Kai ; Shaw, Simon ; Augustijn, Hannah E. et al. / AntiSMASH 7.0 : new and improved predictions for detection, regulation, chemical structures and visualisation. In: Nucleic acids research. 2023 ; Vol. 51, No. W1. pp. W46-W50.
Download
@article{0eef24d7ef45476986edc087bcf46ebe,
title = "AntiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation",
abstract = "Microorganisms produce small bioactive compounds as part of their secondary or specialised metabolism. Often, such metabolites have antimicrobial, anticancer, antifungal, antiviral or other bio-Activities and thus play an important role for applications in medicine and agriculture. In the past decade, genome mining has become a widely-used method to explore, access, and analyse the available biodiversity of these compounds. Since 2011, the 'antibiotics and secondary metabolite analysis shell-antiSMASH' (https://antismash.secondarymetabolites.org/) has supported researchers in their microbial genome mining tasks, both as a free to use web server and as a standalone tool under an OSI-Approved open source licence. It is currently the most widely used tool for detecting and characterising biosynthetic gene clusters (BGCs) in archaea, bacteria, and fungi. Here, we present the updated version 7 of antiSMASH. antiSMASH 7 increases the number of supported cluster types from 71 to 81, as well as containing improvements in the areas of chemical structure prediction, enzymatic assembly-line visualisation and gene cluster regulation.",
author = "Kai Blin and Simon Shaw and Augustijn, {Hannah E.} and Reitz, {Zachary L.} and Friederike Biermann and Mohammad Alanjary and Artem Fetter and Terlouw, {Barbara R.} and Metcalf, {William W.} and Helfrich, {Eric J.N.} and {Van Wezel}, {Gilles P.} and Medema, {Marnix H.} and Tilmann Weber",
note = "Funding Information: Novo Nordisk Foundation [NNF20CC0035580 to T.W., NNF16OC0021746 to T.W.]; Center for Microbial Secondary Metabolites (CeMiSt), Danish National Research Foundation [DNRF137 to T.W.]; ERC Starting Grant [948770-DECIPHER to M.H.M.]; Novel Antibacterial Compounds and Therapies Antagonising Resistance program (NACTAR) from the Dutch Research Council (NWO) [16440 to M.H.M.]; M.A is supported by the NWO Talent programme Veni science domain (VI.Veni.202.130). Funding for open access charge: Novo Nordisk Foundation. ",
year = "2023",
month = jul,
day = "5",
doi = "10.1093/nar/gkad344",
language = "English",
volume = "51",
pages = "W46--W50",
journal = "Nucleic acids research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "W1",

}

Download

TY - JOUR

T1 - AntiSMASH 7.0

T2 - new and improved predictions for detection, regulation, chemical structures and visualisation

AU - Blin, Kai

AU - Shaw, Simon

AU - Augustijn, Hannah E.

AU - Reitz, Zachary L.

AU - Biermann, Friederike

AU - Alanjary, Mohammad

AU - Fetter, Artem

AU - Terlouw, Barbara R.

AU - Metcalf, William W.

AU - Helfrich, Eric J.N.

AU - Van Wezel, Gilles P.

AU - Medema, Marnix H.

AU - Weber, Tilmann

N1 - Funding Information: Novo Nordisk Foundation [NNF20CC0035580 to T.W., NNF16OC0021746 to T.W.]; Center for Microbial Secondary Metabolites (CeMiSt), Danish National Research Foundation [DNRF137 to T.W.]; ERC Starting Grant [948770-DECIPHER to M.H.M.]; Novel Antibacterial Compounds and Therapies Antagonising Resistance program (NACTAR) from the Dutch Research Council (NWO) [16440 to M.H.M.]; M.A is supported by the NWO Talent programme Veni science domain (VI.Veni.202.130). Funding for open access charge: Novo Nordisk Foundation.

PY - 2023/7/5

Y1 - 2023/7/5

N2 - Microorganisms produce small bioactive compounds as part of their secondary or specialised metabolism. Often, such metabolites have antimicrobial, anticancer, antifungal, antiviral or other bio-Activities and thus play an important role for applications in medicine and agriculture. In the past decade, genome mining has become a widely-used method to explore, access, and analyse the available biodiversity of these compounds. Since 2011, the 'antibiotics and secondary metabolite analysis shell-antiSMASH' (https://antismash.secondarymetabolites.org/) has supported researchers in their microbial genome mining tasks, both as a free to use web server and as a standalone tool under an OSI-Approved open source licence. It is currently the most widely used tool for detecting and characterising biosynthetic gene clusters (BGCs) in archaea, bacteria, and fungi. Here, we present the updated version 7 of antiSMASH. antiSMASH 7 increases the number of supported cluster types from 71 to 81, as well as containing improvements in the areas of chemical structure prediction, enzymatic assembly-line visualisation and gene cluster regulation.

AB - Microorganisms produce small bioactive compounds as part of their secondary or specialised metabolism. Often, such metabolites have antimicrobial, anticancer, antifungal, antiviral or other bio-Activities and thus play an important role for applications in medicine and agriculture. In the past decade, genome mining has become a widely-used method to explore, access, and analyse the available biodiversity of these compounds. Since 2011, the 'antibiotics and secondary metabolite analysis shell-antiSMASH' (https://antismash.secondarymetabolites.org/) has supported researchers in their microbial genome mining tasks, both as a free to use web server and as a standalone tool under an OSI-Approved open source licence. It is currently the most widely used tool for detecting and characterising biosynthetic gene clusters (BGCs) in archaea, bacteria, and fungi. Here, we present the updated version 7 of antiSMASH. antiSMASH 7 increases the number of supported cluster types from 71 to 81, as well as containing improvements in the areas of chemical structure prediction, enzymatic assembly-line visualisation and gene cluster regulation.

UR - http://www.scopus.com/inward/record.url?scp=85160292286&partnerID=8YFLogxK

U2 - 10.1093/nar/gkad344

DO - 10.1093/nar/gkad344

M3 - Article

C2 - 37140036

AN - SCOPUS:85160292286

VL - 51

SP - W46-W50

JO - Nucleic acids research

JF - Nucleic acids research

SN - 0305-1048

IS - W1

ER -